Condition category
Cancer
Date applied
13/09/2005
Date assigned
17/10/2005
Last edited
10/05/2012
Prospective/Retrospective
Prospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Contact information

Type

Scientific

Primary contact

Prof Michael King

ORCID ID

Contact details

Dept Mental Health Sciences
Royal Free and University College Medical School
Rowland Hill Street
London
NW3 2PF
United Kingdom
+44 (0)20 7794 0500
m.king@medsch.ucl.ac.uk

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

SDO/13/2001 (e)

Study information

Scientific title

Acronym

Study hypothesis

That the development and testing of a complex intervention will lead to improved continuity of care in cancer for patients and those close to them by the delivery of the planned intervention.

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type

Other

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Continuity of care in cancer

Intervention

A feasibility (phase II) randomised trial in which we are developing and testing a new intervention - this will be a form of care record for teams in which aspects of continuity of care for each patient will be assessed.
ECAP - engagement and continuity action plan: a continuity of care risk assessment completed by secondary care workers at multi-disciplinary meeting.

Intervention type

Other

Phase

Phase II

Drug names

Primary outcome measures

1. Acceptability
2. Practicality and feasibility of ECAP
3. Improved patient experience of engagement with care

Secondary outcome measures

1. Economic benefits
2. Patient and nominated friend/family member well being

Overall trial start date

01/04/2006

Overall trial end date

30/09/2007

Reason abandoned

Eligibility

Participant inclusion criteria

1. Aged over 18 years
2. Able to give informed consent
3. Patients diagnosed with breast, lung or colorectal cancer, or their nominated relative or friend

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

80 patients with up to two nominated relatives or friends

Participant exclusion criteria

1. Unable to give informed consent
2. Aged under 18 years

Recruitment start date

01/04/2006

Recruitment end date

30/09/2007

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Dept Mental Health Sciences
London
NW3 2PF
United Kingdom

Sponsor information

Organisation

University College London (UK)

Sponsor details

Gower Street
London
WC1E 6BT
United Kingdom
+44 (0)20 7679 2000
vicky.latter@royalfree.nhs.uk

Sponsor type

University/education

Website

Funders

Funder type

Government

Funder name

NHS Service and Delivery Organisation (UK) [ref: SDO/13/2001 (e)]

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

2007 results in http://www.ncbi.nlm.nih.gov/pubmed/19107130

Publication citations

  1. Results

    King M, Jones L, McCarthy O, Rogers M, Richardson A, Williams R, Tookman A, Nazareth I, Development and pilot evaluation of a complex intervention to improve experienced continuity of care in patients with cancer., Br. J. Cancer, 2009, 100, 2, 274-280, doi: 10.1038/sj.bjc.6604836.

Additional files

Editorial Notes